Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Biomaterials|October 21, 2022
On-demand targeting nanotheranostics with stimuli-responsive releasing property to improve delivery efficiency to cancerHongwei Lu, Ji Xu, Jinfan Yang, et al.Frontiers in Immunology|November 22, 2021
Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex ImmunofluorescenceHaoxin Peng, Xiangrong Wu, Ran Zhong, et al.International Clinical Psychopharmacology|January 12, 2012
Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophreniaMaosheng Fang, Honghui Chen, Le-Hua Li, et al.Stroke|August 20, 2015
Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in ChinaZhongrong Miao, Yong Zhang, Jie Shuai, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 23, 2023
Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatmentHaijing Qu, Jinfan Yang, Shuaijun Li, et al.Cell Reports. Medicine|June 30, 2026
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trialHuan Yan, Wenjuan Jiang, Yi Xiong, et al.Stroke and Vascular Neurology|October 9, 2018
Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry studyNing Ma, Yong Zhang, Jie Shuai, et al.Journal of Neurointerventional Surgery|December 14, 2020
Balloon-mounted stenting for ICAS in a multicenter registry study in China: a comparison with the WEAVE/WOVEN trialKaijiang Kang, Yong Zhang, Jie Shuai, et al.Radiology|January 20, 2026
Drug-coated Balloon for Endovascular Treatment of Symptomatic Intracranial Stenotic Disease: A Multicenter Randomized Controlled TrialSheng Guan, Xu Tong, Xiaoqing Li, et al.Signal Transduction and Targeted Therapy|April 18, 2024
The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trialBo Cheng, Caichen Li, Jianfu Li, et al.Pageof 10